Abbott Laboratories announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced sales was USD 7,765 million compared to USD 7,589 million a year ago. Operating income was USD 1,165 million compared to USD 651 million a year ago. Net income was USD 654 million compared to net loss of USD 828 million a year ago. Diluted earnings per share from continuing operations was USD 0.37 compared to diluted loss per share from continuing operations of USD 0.5 a year ago. Diluted earnings per share was USD 0.37 compared to diluted loss per share of USD 0.48 a year ago. For the full year, sales was USD 30,578 million compared to USD 27,390 million a year ago. Operating income was USD 3,650 million compared to USD 1,564 million a year ago. Net income was USD 2,368 million compared to USD 477 million a year ago. Diluted earnings per share from continuing operations was USD 1.31 compared to USD 0.2 a year ago. Diluted earnings per share was USD 1.33 compared to USD 0.27 a year ago.